Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Atypical teratoid/rhabdoid tumor (AT/RT) arising from the acoustic nerve in a young adult: a case report and a review of literature.

Medicine·2015
Same author

Extensive cerebral microbleeds predict parenchymal haemorrhage and poor outcome after intravenous thrombolysis.

Journal of neurology, neurosurgery, and psychiatry·2015
Same author

The role of contrast-enhanced ultrasound (CEUS) in the early assessment of microvascularization in patients with aggressive B-cell lymphoma treated by rituximab-CHOP: a preliminary study.

Clinical hemorheology and microcirculation·2015
Same author

Global analysis of gene expression profiles in physic nut (Jatropha curcas L.) seedlings exposed to drought stress.

BMC plant biology·2015
Same author

Rapid adsorption of 2,4-dichlorophenoxyacetic acid by iron oxide nanoparticles-doped carboxylic ordered mesoporous carbon.

Journal of colloid and interface science·2015
Same author

Endostar in combination with modified FOLFOX6 as an initial therapy in advanced colorectal cancer patients: a phase I clinical trial.

Cancer chemotherapy and pharmacology·2015
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Reply to "Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities".

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Correlates and predictors of self-efficacy among dementia caregivers: D-CARE findings.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

What should convince a clinician of disease modification in Alzheimer's disease clinical trials?

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Primary cilia-extracellular vesicle crosstalk in Alzheimer's disease: Emerging mechanisms and biomarker potential.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Weitao Yu1, Sheng Zhang2

  • 1Hangzhou Normal University, Hangzhou, Zhejiang, China.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
PubMed
概括
此摘要是机器生成的。

扫描源光学连贯断层扫描血管造影 (SS-OCTA) 显示,在脑小血管疾病 (CSVD) 患者中查轻度认知障碍 (MCI) 是有前途的. 使用SS-OCTA进行斑点 perfusion 区域测量是有效的MCI查标志物.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 眼科医生 眼科 眼科
  • 神经学 神经学
  • 医疗成像医学成像

背景情况:

  • 大脑小血管疾病 (CSVD) 与轻度认知障碍 (MCI) 有关.
  • 在CSVD患者中开发有效的MCI查工具至关重要.
  • 扫描源光学连贯断层扫描血管学 (SS-OCTA) 提供眼睛血管系统的高分辨率成像.

研究的目的:

  • 开发和验证用于查CSVD患者的MCI的新生物标志物.
  • 评估SS-OCTA在检测MCI相关变化的有效性.
  • 为了确定特定的SS-OCTA参数,表明CSVD中的MCI.

主要方法:

  • 来自Dream-10和FRESH-CSVD研究中的MCI和正常认知 (NC) 参与者的未来招聘.
  • 使用血生物标志物的阿尔茨海默病 (AD) 患者排除.
  • 分类为开发和验证队列;LASSO回归用于标记物选择和时间验证.

主要成果:

  • 招募了102名参与者 (59.8%的MCI).
  • 发育队列确定了左横旋体积,右状体积和黄斑 perfusion 区域 (0-3mm 和 0-6mm) 作为MCI标志物.
  • 验证队列证实了0-3mm和0-6mm的黄斑冠状透区 (CCPA) 作为优越的MCI标志物 (AUC>0.83).

结论:

  • SS-OCTA,特别是黄斑CCPA,显示出在CSVD患者中查MCI的巨大潜力.
  • 这些发现表明,SS-OCTA可以作为一种非侵入性工具,用于在这个人群中早期检测MCI.
  • 进一步的研究可能会完善SS-OCTA在管理CSVD相关认知衰退中的作用.